J&J is looking to add a hormone-sensitive indication to its prostate cancer therapy, which was originally approved in 2023.

An estimated 20 million people are diagnosed annually with cancer, while cancer kills almost 10 million people a year ...

Spoiler alert for the June 26, 2025 episode of “And Just Like That” And just like that … Harry Goldenblatt has prostate ...

J&J has rights to niraparib in prostate cancer, and views the drug as a successor to Zytiga, once a $2.5 billion-a-year ...

Prostate cancer is a significant health concern for men worldwide, with increasing diagnoses and fatalities projected. Early ...

A genetics research laboratory has reached a significant milestone in its efforts to recruit 1,000 volunteers for a prostate ...

Bacteria in the urinary tract can convert corticosteroids into androgens, hormones that promote the growth of prostate cancer ...

Australians in their 30s and 40s are being diagnosed with cancer at unprecedented rates, with at least 10 types of the ...

A new study from the University of Michigan Rogel Health Cancer Center, published in Science , sheds light on how two ...